Abstract
Craniopharyngiomas are rare brain tumors of the sellar/suprasellar region, often adversely affecting patients’ physical and psychosocial functioning. Until a few years ago, knowledge on cognitive deficits in craniopharyngioma patients was based on little valid evidence, with considerable inconsistencies across studies. Findings from recent research, with partly larger sample sizes, add to existing evidence to provide a more clear and reliable picture. The current review aims to summarize and systemize current findings on cognitive deficits in childhood craniopharyngioma, taking account of patient- and treatment-related variables where possible. Those studies were included that reported results of childhood craniopharyngioma patients tested with formalized neuropsychological tests (irrespective of their age at study, group size ≥10). A systematic assignment of test results to subcomponents of broader cognitive domains (e.g. to specific memory systems and processes) allows for a first comprehensive overview of patterns of spared and impaired cognitive functions. We show that episodic memory recall in particular is impaired, largely sparing other memory components. In accordance with recent knowledge on mammillary function, patients with hypothalamic involvement appear to be at particular risk. Deficits in higher cognitive processes, relying on the integrity of the prefrontal cortex and its subcortical pathways, may also occur, but results are still inconsistent. To gain deeper insight into the pattern of deficits and their association with patient- and treatment-related variables, further multi-site research with larger cohorts is needed.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Craniopharyngiomas are rare primary brain tumors of low-grade malignancy (WHO, grade I), most commonly found within the sellar/and or parasellar region. The tumor may occur at any age, but approximately 30–50 % of all cases are diagnosed during childhood and adolescence [1]. Due to their close anatomical proximity to the hypothalamus, the pituitary, and the optic nerves, craniopharyngiomas are frequently associated with visual, endocrine and neurobehavioral deficits which may seriously limit functional capacity and quality of life. Within the past three decades, advances in treatment strategies and techniques have led to decreasing mortality and less severe morbidity. Improved outcomes have encouraged researchers to increasingly focus attention on issues related to neurobehavioral, social, and emotional dysfunctions [2, 3], and quality of life, including cognitive functions [4–8].
Up until a few years ago, the great majority of studies which claimed to account for cognitive performance either used (i) standardized intelligence testing to assess global cognitive functioning [7, 9–13], or (ii) educational achievement, subsequent employment or IQ scores, as well as a combination of these to indicate outcome [14–20]. Characterization of deficits in different cognitive domains had received little attention and the few studies, which used formal neuropsychological testing, yielded heterogeneous results. Some studies found deficits in memory [21, 22], executive functions [22], attention [23] or processing speed [24, 25], while others did not (see for memory [25, 26], executive functions [26], attention [24, 26]). Interestingly, IQ was shown to be within normal limits in the great majority of studies, e.g. [21, 24, 25].
Research conducted in the last few years [27–29], with partly larger sample sizes and higher methodological quality, add to existing evidence and may provide a clearer and more unified picture regarding patterns of spared and impaired functions. Patient and treatment related variables that may additionally affect physical status and cognitive outcomes, like lesion site, radiation therapy, and age at treatment are now being increasingly taken into account and are especially promising in studies with larger sample sizes [23, 28, 29].
With respect to lesion site, it has been known for a long time that hypothalamic damage, caused by the tumor and/or its treatment, is associated with particular adverse endocrine and autonomic outcomes [30]. More recent evidence revealed that hypothalamic involvement may also adversely affect quality of life and cognitive status [3, 6, 8, 27, 28, 31]. Moreover, as the mammillary bodies at the posterior margin of the hypothalamus are known to be crucial for learning and memory, it is likely that the site of the lesion within the hypothalamus is of additional relevance [27].
To our knowledge, this is the first systematic analysis of cognitive outcome in craniopharyngioma patients. The objective of the review was to systemize the findings of studies that used formalized neuropsychological testing to investigate subcomponents of cognition. Analyzing subcomponents of cognition rather than overall cognitive outcome may help to understand the specific difficulties of the patients and to provide appropriate support measures. Due to the paucity of studies available, we included both, comparisons based on control groups and those based on age appropriate norms.
Methods
Note that a systematic review generally provides information on a higher number of patients than available for the current review. However, to ensure a high quality in reporting, the review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines [32].
Search strategy
We systematically searched the whole databases of Medline (via the PubMed interface), Web of Science, and PsycINFO (psychology and psychiatry literature) up to April 2014. A final additional search was performed in January 2015, shortly before submission. The full electronic search strategy was conducted in all fields as follows:
craniopharyngioma AND (child* OR pediatric OR adolescen*) AND (cognit* OR neuropsycholog* OR psycholog* OR memory OR attention OR executive OR neurobehavioral OR intelligence OR IQ OR processing speed).
In addition, reference lists of all included articles and of reviews were hand-searched to identify additional studies relevant to the topic of the current article.
Study selection
Study inclusion and exclusion criteria were developed prior to the study selection process. The following inclusion criteria were used: (a) peer reviewed articles published in English or German, (b) childhood-onset craniopharyngioma patients, irrespective of their age at testing (c) studies with both, adulthood and childhood onset craniopharyngioma patients only, if results of the latter were reported separately, (d) group size for cognitive assessments of at least 10 patients, (e) use of formalized neuropsychological testing to assess cognitive functioning beyond mere overall cognitive assessment (IQ testing), (f) proper characterization/referencing of the tests used, (g) results of each distinct neuropsychological test specified separately, (h) outcome measures that allowed for an assessment of statistical significance. For study selection, full-text articles of all studies were obtained, except for those in which lack of eligibility was obvious from the title or abstract. In a first step, each article was assessed for the first four inclusion criteria by one reviewer (J.Ö). As a second step, all articles reporting cognitive outcomes for childhood craniopharyngioma groups of eligible study size were assessed for the last four eligibility criteria by two reviewers independently (J.Ö. and C.M.T; N = 40). Disagreements between the reviewers were discussed to reach consensus. Where uncertainties remained, a further reviewer (H.L.M.) was asked for clarification.
Data extraction
For the articles included in the review, data were extracted independently by two investigators (J.Ö and C.M.T), using a specifically designed form that included author and year of publication, study location, time of first treatment, primary objective, study design, eligibility criteria, study and comparison groups, treatment/interventions, hypothalamic involvement (pre-operative tumor involvement and/or post-operative hypothalamic lesion), complications, neuropsychological tests used, and cognitive outcome. Where relevant information was found to be missing in the studies or inconsistencies were detected, the study authors were contacted by email and asked for clarification. In some studies that used age appropriate norms, only the number of patients with performance in the clinical range was reported [24, 25]. In these cases, we performed binominal distribution analyses to assess (for a given clinical cut-off value) whether the proportion of individuals exhibiting impaired performance significantly exceeded a specific proportion that would be expected for the general population. Formal meta-analyses could not be performed due to a paucity of studies that investigated distinct cognitive domains with commonly-employed outcome measures.
Results
Included studies
The flow of papers for review and the study selection process are depicted in Fig. 1. The database searches identified 229 non-duplicate and potentially relevant references. 21 additional articles were identified by hand searching. Thus, a total of 250 articles were screened and in a first step, 83 were excluded based on title and abstract. In a second step, full-texts of the remaining 167 articles were retrieved and reviewed. The review process resulted in the exclusion of 158 articles not meeting eligibility criteria and the inclusion of nine articles eligible for further qualitative synthesis.
Description of included studies
Details of the nine studies are depicted in Table 1. All of these studies were published within the last 17 years, five of them even within the past 6 years [26–29, 33]. Most of them aimed at assessing the cognitive status after surgical treatment for childhood craniopharyngioma, providing results based on data from one assessment, with a median period from diagnosis/first treatment to assessment ranging from <3 month to 20 years. [21, 24–28, 33]. Two studies reported results from one and the same prospective longitudinal intervention trial, explicitly focusing on the effects of radiotherapy on memory [29] and attentional performance [23]. These studies had a partly overlapping sample and provided results which were obtained prior to conformal radiation therapy (CRT) (baseline), at different times after initial therapy, up to 5 years after radiation therapy. Sample sizes of participants attending the neuropsychological tests ranged from n = 10 [24] to n = 44 [29], with a median cohort size of n = 16 and were higher in two of the most recent studies [28, 29], compared to older studies. Overall, studies covered results on patients who were first diagnosed and treated between 1958 and 2010. One of the most recent studies covered patients where the operation took place up to 40 years ago [28]. Within studies that provided data from one assessment, the use of a control group, besides merely reporting norm-based outcomes, is common to the more recent ones [26–28]. Unfortunately, detailed neuroradiological assessment of tumor or lesion site with respect to the hypothalamus was only performed in few of the studies that aimed to test cognitive functioning [21, 27, 28]. The two most recent studies, however, explicitly investigated the effect of hypothalamic involvement on cognitive performance [27, 28]. In addition to whole group comparisons (all patients vs. controls), Fjalldal et al. [28] conducted analyses where patients with and without hypothalamic involvement were separated to compare each of the groups to their matched controls.
Information relevant for the interpretation of the results was found to be missing in some studies [24–26, 33]. In these cases, the corresponding author or senior author was contacted with a request for clarification and as far as additional information was provided, this was included in Table 1 and Supplement 1 (Table S1) and identified as such.
Neuropsychological tests
All tests, which were used to examine individual cognitive domains, are shortly outlined in Table S1 (Supplement 1). In addition, the table provides information regarding the key measures of the tests that were used in each individual study. For further information on neuropsychological tests see Strauss et al. [34].
General cognitive functioning
With the exception of one study [26], which observed significantly lower scores for patients’ performance IQ compared to a healthy control group, IQ was reported to be in the normal range or not different from healthy controls [21, 24, 25, 27, 33]
Memory performance
Results for different memory domains are depicted in Table 2. Five of the seven studies which tested episodic memory reported deficits in immediate and/or delayed memory retrieval [21, 24, 27, 28, 33]. Interestingly, in studies which tested both, impairments in delayed recall were found together with preserved delayed recognition capabilities [21, 27]. Short-term and working memory [21, 24, 25, 27 and semantic memory [28] were intact in all patient samples tested as a whole. However, in the study by Fjalldal et al. [28], subgroup analyses revealed the particular significance of hypothalamic involvement: Compared to their matched controls, patients with hypothalamic involvement were significantly impaired in episodic recall and semantic memory, whereas patients without hypothalamic involvement were not impaired.
Language and visual abilities
Word retrieval was found to be impaired in one study [21] whereas both, word retrieval and passage comprehension, were preserved in another study [24] (Table 2). With the exception of one study [29], all studies that tested visuo-spatial long-term memory also assessed performance in visuo-spatial or visuo-perceptual abilities and none of them could find impairments in the patient group (see Table 2).
Processing speed, attention, and executive functioning
All three studies that tested processing speed found significantly impaired performance in patients compared either to healthy controls [28] or to age appropriate norms [24, 25]. Mixed findings were observed with other tests assessing attention and executive performance (Table 3).
Patient- and treatment-related variables
Very few of the studies could find a significant effect of patient- and treatment-related variables on cognitive performance (Table 1). In the study by Özyurt et al. [27], multiple linear regression analyses revealed that a higher degree of postoperative hypothalamic involvement predicted worse sustained attentional performance. In the study by Fjalldal et al. [28], a negative correlation was found between years since surgical treatment and the mean z-score of all cognitive tests. Additional analyses revealed that reduced cognitive performance mainly in patients with hypothalamic involvement were responsible for this finding. In the study by Di Pinto et al. [29], hydrocephalus, shunt insertion, and female gender were found to be predictive of worse episodic learning performance 5 years after conformal radiation therapy.
Discussion
In accordance with several other reports [35–37] (but also see [11, 38] ), all reviewed studies that included intelligence testing obtained a full-scale IQ in the normal range for the patient group [21, 24–27, 33]. Despite preserved overall cognitive abilities, patients revealed deficits in specific neuropsychological test assessing memory, attention, processing speed, and executive functioning. This implies that the full scale IQ either masks deficits in individual subtests or that the IQ (sub-) tests largely do not cover assessment of cognitive subprocesses that may be affected in craniopharyngioma patients.
Memory performance
Based on anatomical considerations and frequently reported complaints of the patients and/or their caregivers, learning and memory was the domain most investigated in patients with childhood craniopharyngioma. A systemized assignment of test results to subcomponents of memory, as shown in Table 2, demonstrates a clear pattern of spared and impaired memory functions. In the literature reviewed, verbal and visuo-spatial memory span and working memory were found to be in the normal range [21, 24, 25] and not different from controls [27]. A different picture emerged when information to be retained exceeded immediate memory span and had to be recalled either immediately or after a delay. In several studies, verbal and/or visual episodic memory were significantly impaired [21, 24, 27, 28, 33], despite normal language [24] and visuo-spatial abilities [21, 28, 33]. However, some inconsistencies remain regarding the question, whether deficits in delayed recall are indicative of a true retrieval deficit [21, 27], or solely due to impairments already obvious at the immediate recall stage [28] (which could be due to an encoding deficit).
In the study by Fjalldal et al. [28], additional subgroup analyses indicated that patients with hypothalamic involvement were mainly responsible for the memory deficits reported for the whole patient group. The finding of episodic memory deficits, with hypothalamic involvement in particular, is in line with the importance of the mammillary part of the hypothalamus for the extended hippocampal system, which is known to be vital for episodic memory [39–41]. Noteworthy, two studies that tested both, episodic recall and recognition performance, suggested impaired delayed recall together with relatively preserved delayed recognition [21, 27]. A similar dissociation has been reported in previous studies in patients with damage to the mammillary bodies or its connections [40, 41].
Attention, processing speed and executive functioning
Hypothalamic involvement is frequently associated with neurobehavioral problems which may be indicative of frontal dysfunctions, such as emotional lability, rage attacks, deficits in memory and higher cognitive abilities [16, 42, 43]. Regarding patients treated in the pre-microsurgical era, those deficits have been ascribed to frontal damage induced by surgery [22, 25]. However, it is conceivable that hypothalamic damage itself may result in a loss of input to prefrontal regions, leading to deficits in executive and attentional control [44, 45]. Currently, the evidence base for functioning in these cognitive domains is still rather limited.
Within the articles reviewed, cognitive flexibility is the only executive function that was tested in more than one study. This cognitive component, which is of vital importance for the ability to adapt to changing situations and goals, was shown to be significantly impaired in one study [27], but unimpaired in two others [25, 26]. Outside the set of publications considered for this review, additional evidence for executive dysfunctions comes from a study that observed impaired cognitive flexibility in a childhood craniopharyngioma group treated with radical surgery [22] and another study that used a standardized questionnaire to assess everyday problems with executive functions [3].
Sustained attention, with its requirement for top-down monitoring and control, is a further cognitive component, which is in part mediated by the frontal lobes. Two of the included studies found impairments in sustained attention [27, 28]. On the other hand, two other studies found patient’s performance in the normal range [24] or not different from the control group [26].
Processing speed has been frequently observed to be impaired in survivors of childhood brain tumors [46] and was shown to be critically dependent on the structural integrity of white matter pathways to frontal, parietal and temporal cortices [47]. Fronto-thalamic pathways, which may be affected by a tumor or its treatment, are assumed to play an important role in modulating the efficiency of information processing [48]. Processing speed was tested in three of the studies included and all reported a significant proportion of patients in the clinical range or a significantly slower performance compared to controls [24, 25, 28].
Effects of radiotherapy on memory performance and attention
Radiation therapy of brain tumors has often been found to significantly heighten the risk of neurocognitive deficits [49]. Within the last decade, more refined irradiation methods have been established, being further developed on a continuous basis. With its potential to better target the tumor and to spare healthy brain tissue, CRT in particular is assumed to result in less cognitive sequelae compared to previous methods [49]. Two studies, reporting results from a longitudinal trial and with partly overlapping samples, investigated the impact of CRT on cognition up to 5 years after irradiation. Di Pinto et al. [29] reported episodic learning performance in the normal range at baseline, with no performance decline in the further course of the study. On the other hand, Kiehna et al. [23] found sustained attentional performance in the borderline normal range at baseline assessment and a significant decline during radiation, up to five years after completion of the therapy. It was, however, pointed out that this performance decline was likely not caused by CRT alone, as comparable courses of outcome have been reported after surgery alone [23].
Other patient- and treatment-related variables
Besides hypothalamic involvement and radiation therapy, numerous other factors can influence cognitive outcomes, and their identification may be crucial for informed treatment decisions. Presumably due to the mostly small sample sizes and an associated lack of statistical power, few significant findings were available from the studies included. Two more recent studies, comprising larger cohort sizes, identified a small number of relevant patient- and treatment related variables. The negative correlation between years since surgical treatment and global performance, reported for patients with hypothalamic involvement in the study by Fjalldal et al. [28], was possibly due to late effects associated with irradiation of normal brain tissue. This interpretation is supported by the fact that the large majority of the patients had received radiation therapy, with the first patients’ treatment dating back to the late fifties. The finding of younger age at radiation therapy as predictor for worse cognitive performance in the study by Di Pinto et al. [29] is also well in line with other studies [13, 22, 50] and clearly supports approaches to delay radiation in very young patients [51]. In the same study, hydrocephalus and shunt insertion also predicted worse cognitive performance, illustrating the relevance of an early identification and treatment of hydrocephalus [23].
Limitations
The interpretation of the findings is limited by the paucity of studies that tested specific cognitive functions. In addition, the limited number of studies eligible for the review and the small sample sizes in most of these studies clearly restrict the conclusions on the influence of patient and treatment variables on cognitive outcomes (e.g. hypothalamic involvement, presence of hydrocephalus, type and extent of surgery, irradiation). Finally it should be noted that some of the studies were of poor to limited quality.
Conclusions and future directions
Research published within the last years, added new evidence providing a clearer and more reliable picture of cognitive sequelae associated with childhood craniopharyngioma. The current summary of available findings indicates dysfunctions in cognitive processes mediated by extended hippocampal and fronto-hypothalamic pathways [52]. Episodic long-term memory in particular is shown to be affected in patients, and hypothalamic involvement was shown to be an essential risk factor for adverse outcomes. We believe that this review will provide a starting point for more targeted cognitive testing. There is an urgent need for studies with larger sample sizes, ideally conducted as part of follow-up protocols that are used by multiple centers in parallel, to enable more in-depth insights into cognitive deficits and their relation to patient- and treatment-related variables. As results of cognitive testing cover only part of psychological outcomes and may in some cases significantly differ from patients’ subjective evaluation or overall functional outcome, these objective neuropsychological measures should be combined with measures of quality of life and of neurobehavioral, social and emotional/affective outcomes. In Supplement 2, we provide recommendations for a set of domain-specific neuropsychological tests that may be used for research or clinical practice, and a list of further key clinical variables to include in future reports that focus on psychological outcomes.
References
Muller HL (2010) Childhood craniopharyngioma–current concepts in diagnosis, therapy and follow-up. Nat Rev Endocrinol 6(11):609–618. doi:10.1038/nrendo.2010.168
Zada G, Kintz N, Pulido M, Amezcua L (2013) Prevalence of neurobehavioral, social, and emotional dysfunction in patients treated for childhood craniopharyngioma: a systematic literature review. PLoS One 8(11):e76562. doi:10.1371/journal.pone.0076562
Laffond C, Dellatolas G, Alapetite C, Puget S, Grill J, Habrand JL, Doz F, Chevignard M (2012) Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy. Brain Inj 26(3):270–281. doi:10.3109/02699052.2011.648709
Muller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kuhl J, Gutjahr P, Sorensen N, Calaminus G (2001) Obesity after childhood craniopharyngioma–German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr 213(4):244–249. doi:10.1055/s-2001-16855
Muller HL (2013) Paediatrics: surgical strategy and quality of life in craniopharyngioma. Nat Rev Endocrinol 9(8):447–449. doi:10.1038/nrendo.2013.125
Muller HL, Bruhnken G, Emser A, Faldum A, Etavard-Gorris N, Gebhardt U, Kolb R, Sorensen N (2005) Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. Child’s Nerv Syst 21(11):975–980. doi:10.1007/s00381-004-1124-y
Merchant TE, Kiehna EN, Sanford RA, Mulhern RK, Thompson SJ, Wilson MW, Lustig RH, Kun LE (2002) Craniopharyngioma: the St. Jude Children’s Research Hospital experience 1984–2001. Int J Radiat Oncol Biol Phys 53(3):533–542
Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E (2004) Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46(4):220–229
Netson KL, Conklin HM, Wu S, Xiong X, Merchant TE (2013) Longitudinal investigation of adaptive functioning following conformal irradiation for pediatric craniopharyngioma and low-grade glioma. Int J Radiat Oncol Biol Phys 85(5):1301–1306. doi:10.1016/j.ijrobp.2012.10.031
Merchant TE, Kiehna EN, Kun LE, Mulhern RK, Li C, Xiong X, Boop FA, Sanford RA (2006) Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg 104(2 Suppl):94–102. doi:10.3171/ped.2006.104.2.5
Pedreira CC, Stargatt R, Maroulis H, Rosenfeld J, Maixner W, Warne GL, Zacharin MR (2006) Health related quality of life and psychological outcome in patients treated for craniopharyngioma in childhood. J Pediatr Endocrinol Metab 19(1):15–24
Galatzer A, Nofar E, Beit-Halachmi N, Aran O, Shalit M, Roitman A, Laron Z (1981) Intellectual and psychosocial functions of children, adolescents and young adults before and after operation for craniopharyngioma. Child Care Health Dev 7(6):307–316
Eiser C (1981) Psychological sequelae of brain tumours in childhood: a retrospective study. Br J Clin Psychol 20(Pt 1):35–38
Anderson CA, Wilkening GN, Filley CM, Reardon MS, Kleinschmidt-DeMasters BK (1997) Neurobehavioral outcome in pediatric craniopharyngioma. Pediatr Neurosurg 26(5):255–260
Schubert T, Trippel M, Tacke U, van Velthoven V, Gumpp V, Bartelt S, Ostertag C, Nikkhah G (2009) Neurosurgical treatment strategies in childhood craniopharyngiomas: is less more? Child’s Nerv Syst 25(11):1419–1427. doi:10.1007/s00381-009-0978-4
Pierre-Kahn A, Recassens C, Pinto G, Thalassinos C, Chokron S, Soubervielle JC, Brauner R, Zerah M, Sainte Rose C (2005) Social and psycho-intellectual outcome following radical removal of craniopharyngiomas in childhood. A prospective series. Child’s Nerv Syst 21(8–9):817–824. doi:10.1007/s00381-005-1205-6
Thompson D, Phipps K, Hayward R (2005) Craniopharyngioma in childhood: our evidence-based approach to management. Child’s Nerv Syst 21(8–9):660–668. doi:10.1007/s00381-005-1210-9
Mottolese C, Szathmari A, Berlier P, Hermier M (2005) Craniopharyngiomas: our experience in Lyon. Child’s Nerv Syst 21(8–9):790–798. doi:10.1007/s00381-005-1242-1
Kalapurakal JA, Goldman S, Hsieh YC, Tomita T, Marymont MH (2003) Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med Pediatr Oncol 40(4):214–218. doi:10.1002/mpo.10247
Colangelo M, Ambrosio A, Ambrosio C (1990) Neurological and behavioral sequelae following different approaches to craniopharyngioma. Child’s Nerv Syst 6(7):379–382
Carpentieri SC, Waber DP, Scott RM, Goumnerova LC, Kieran MW, LE Cohen, Kim F, Billett AL, Tarbell NJ, Pomeroy SL (2001) Memory deficits among children with craniopharyngiomas. Neurosurg 49(5):1053–1057 (discussion 1057–1058)
Cavazzuti V, Fischer EG, Welch K, Belli JA, Winston KR (1983) Neurological and psychophysiological sequelae following different treatments of craniopharyngioma in children. J Neurosurg 59(3):409–417. doi:10.3171/jns.1983.59.3.0409
Kiehna EN, Mulhern RK, Li C, Xiong X, Merchant TE (2006) Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol 24(33):5283–5290. doi:10.1200/jco.2005.03.8547
Waber DP, Pomeroy SL, Chiverton AM, Kieran MW, Scott RM, Goumnerova LC, Rivkin MJ (2006) Everyday cognitive function after craniopharyngioma in childhood. Pediatr Neurol 34(1):13–19. doi:10.1016/j.pediatrneurol.2005.06.002
Riva D, Pantaleoni C, Devoti M, Saletti V, Nichelli F, Giorgi C (1998) Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma. Child’s Nerv Syst 14(4–5):179–184
Bawden HN, Salisbury S, Eskes G, Morehouse R (2009) Neuropsychological functioning following craniopharyngioma removal. J Clin Exp Neuropsychol 31(1):140–144. doi:10.1080/13803390802064599
Ozyurt J, Thiel CM, Lorenzen A, Gebhardt U, Calaminus G, Warmuth-Metz M, Muller HL (2014) Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement. J Pediatr 164(4):876–881. doi:10.1016/j.jpeds.2013.12.010 e874
Fjalldal S, Holmer H, Rylander L, Elfving M, Ekman B, Osterberg K, Erfurth EM (2013) Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma. J Clin Endocrinol Metab 98(8):3253–3262. doi:10.1210/jc.2013-2000
Di Pinto M, Conklin HM, Li C, Merchant TE (2012) Learning and memory following conformal radiation therapy for pediatric craniopharyngioma and low-grade glioma. Int J Radiat Oncol Biol Phys 84(3):e363–369. doi:10.1016/j.ijrobp.2012.03.066
de Vile CJ, Grant DB, Hayward RD, Kendall BE, Neville BG, Stanhope R (1996) Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging. J Clin Endocrinol Metab 81(7):2734–2737. doi:10.1210/jcem.81.7.8675604
Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, Zerah M, Bezerra M, Renier D, Pierre-Kahn A, Sainte-Rose C (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg 106(1 Suppl):3–12. doi:10.3171/ped.2007.106.1.3
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100. doi:10.1371/journal.pmed.1000100
Ondruch A, Maryniak A, Kropiwnicki T, Roszkowski M, Daszkiewicz P (2011) Cognitive and social functioning in children and adolescents after the removal of craniopharyngioma. Child’s Nerv Syst 27(3):391–397. doi:10.1007/s00381-010-1301-0
Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests. Oxford University Press, Oxford, New York
Hoffman HJ, De Silva M, Humphreys RP, Drake JM, Smith ML, Blaser SI (1992) Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 76(1):47–52. doi:10.3171/jns.1992.76.1.0047
Flick T, Michel M (1986) Rehabilitation of young craniopharyngioma patients. Rehabil (Stuttg) 25(2):45–52
Clopper RR, Meyer WJ 3rd, Udvarhelyi GB, Money J, Aarabi B, Mulvihill JJ, Piasio M (1977) Postsurgical IQ and behavioral data on twenty patients with a history of childhood craniopharyngioma. Psychoneuroendocrinology 2(4):365–372
Dhellemmes P, Vinchon M (2006) Radical resection for craniopharyngiomas in children: surgical technique and clinical results. J Pediatr Endocrinol Metab 19(Suppl 1):329–335
Aggleton JP (2012) Multiple anatomical systems embedded within the primate medial temporal lobe: implications for hippocampal function. Neurosci Biobehav Rev 36(7):1579–1596. doi:10.1016/j.neubiorev.2011.09.005
Vann SD (2010) Re-evaluating the role of the mammillary bodies in memory. Neuropsychologia 48(8):2316–2327. doi:10.1016/j.neuropsychologia.2009.10.019
Tsivilis D, Vann SD, Denby C, Roberts N, Mayes AR, Montaldi D, Aggleton JP (2008) A disproportionate role for the fornix and mammillary bodies in recall versus recognition memory. Nat Neurosci 11(7):834–842. doi:10.1038/nn.2149
Muller HL (2008) Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm Res 69(4):193–202. doi:10.1159/000113019
Garnett MR, Puget S, Grill J, Sainte-Rose C (2007) Craniopharyngioma. Orphanet J rare Dis 2:18. doi:10.1186/1750-1172-2-18
Lemaire JJ, Frew AJ, McArthur D, Gorgulho AA, Alger JR, Salomon N, Chen C, Behnke EJ, De Salles AA (2011) White matter connectivity of human hypothalamus. Brain Res 1371:43–64. doi:10.1016/j.brainres.2010.11.072
Aggleton JP, Dumont JR, Warburton EC (2011) Unraveling the contributions of the diencephalon to recognition memory: a review. Learn Mem 18(6):384–400. doi:10.1101/lm.1884611
Ellenberg L, Liu Q, Gioia G, Yasui Y, Packer RJ, Mertens A, Donaldson SS, Stovall M, Kadan-Lottick N, Armstrong G, Robison LL, Zeltzer LK (2009) Neurocognitive status in long-term survivors of childhood CNS malignancies: a report from the childhood cancer survivor study. Neuropsychology 23(6):705–717. doi:10.1037/a0016674
Turken A, Whitfield-Gabrieli S, Bammer R, Baldo JV, Dronkers NF, Gabrieli JD (2008) Cognitive processing speed and the structure of white matter pathways: convergent evidence from normal variation and lesion studies. NeuroImage 42(2):1032–1044. doi:10.1016/j.neuroimage.2008.03.057
Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer MG, Weinstock-Guttman B, Benedict RH (2012) Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 259(1):139–146. doi:10.1007/s00415-011-6147-1
Puget S (2012) Treatment strategies in childhood craniopharyngioma. Front Endocrinol 3:64. doi:10.3389/fendo.2012.00064
Jalali R, Mallick I, Dutta D, Goswami S, Gupta T, Munshi A, Deshpande D, Sarin R (2010) Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy. Int J Radiat Oncol Biol Phys 77(4):974–979. doi:10.1016/j.ijrobp.2009.06.025
Muller HL (2013) Childhood craniopharyngioma. Pituitary 16(1):56–67. doi:10.1007/s11102-012-0401-0
Ozyurt J, Lorenzen A, Gebhardt U, Warmuth-Metz M, Muller HL, Thiel CM (2014) Remote effects of hypothalamic lesions in the prefrontal cortex of craniopharygioma patients. Neurobiol Learn Mem. doi:10.1016/j.nlm.2014.03.007
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Financial disclosure
The authors have no financial relationships relevant to this article to disclose.
Funding source
German Childhood Cancer Foundation (DKS 2014.13). The German Childhood Cancer Foundation as the funding source was not involved in the study design; collection, analysis, and interpretation of data; the writing of the report; and the decision to submit the paper for publication.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Özyurt, J., Müller, H.L. & Thiel, C.M. A systematic review of cognitive performance in patients with childhood craniopharyngioma. J Neurooncol 125, 9–21 (2015). https://doi.org/10.1007/s11060-015-1885-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-015-1885-z